The Effect of Magnetic Stimulation on Low Back Pain Relief and Muscle Mass Maintenance in Patients With ESRD

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorBundang CHA Hospital

About this trial

To determine the effectiveness of magnetic stimulation application on alleviating back pain and maintaining muscle mass in patients with end-stage renal disease.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults aged 19 years or older

Patients diagnosed with end-stage renal failure and receiving dialysis treatment more than three times a week

Back pain intensity of 4 points or higher on the visual analogue scale (VAS)

Those with cognitive function that can clearly indicate NRS with a score of 23 points or higher, the criterion for determining cognitive impairment on the Mini Mental State Examination (MMSE) [14]

Disqualifiers

If the pain is due to trauma

If it is difficult to participate in the study due to serious mental illness (e.g. schizophrenia, bipolar disorder, etc.) or psychological instability.

Patients with severe neurological illness (e.g. stroke, severe dementia, etc.).

Those with poor general condition due to unstable cardiovascular, digestive, respiratory, or endocrine systems, or severe internal medical illness such as systemic infection

Trial design

Design model

Single group

Treatments tested in this trial

  • Effects of applying magnetic stimulation

    Device

    The Effect of Magnetic Stimulation on Low Back Pain Relief and Muscle Mass Maintenance in Patients with End-Stage Renal Disease (ESRD)

Treatment groups

18 Participants
are divided into 1 treatment group
Group A: End-Stage Renal Disease patientsExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Visual Analogue Sclae (VAS)

An assessment in which the subject quantifies the level of pain numerically from 0 to 10. The higher the number, the more intense the pain.

Time frame
7 days before intervention/1 day after intervention/1 month after intervention

Secondary outcomes

1

Short Physical Performance Battery (SPPB)

Measures balance, lower extremity strength, and functional ability on a scale of 0 to 16. Higher scores indicate better function.

Time frame
7 days before intervention/1 day after intervention/1 month after intervention
2

The World Health Organization (WHOQOL-BREF)

The WHOQOL-BREF consists of 26 items, with scores ranging from 1 to 5. A higher score indicates a higher quality of life.

Time frame
7 days before intervention/1 day after intervention/1 month after intervention
3

3D Motion Capture

Collecting human body movement data using a 3D infrared camera and ground reaction force device

Time frame
7 days before intervention/1 day after intervention/1 month after intervention
4

Dual Energy X-ray Absorptionmetry (DEXA)

A test that measures muscle mass by utilizing the energy absorption properties of high-energy and low-energy X-rays.

Time frame
7 days before intervention/1 day after intervention/1 month after intervention

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.